Shares fell 9% during the quarter, which offers a compelling entry price now.
CVS dominates with its 'MinuteClinics,' leaving Walgreen in its dust as both face increasing competition from Wal-Mart and Target.
Shares of the world’s largest, most prolific defense contractor offer a rewarding total return based on sustainable payouts to investors.
Yahoo!'s stake in the Chinese Internet company isn't fully factored into the stock price.
Shares are down 16% from Boeing's 52-week high offering a rare opportunity to buy this high-flier on sale.
With new 52-week highs, the ebullient mega-media dynasty's share price may need a spinoff to unlock hidden value for investors.
Income investors are waiting for the health products company to revisit $94, bringing the dividend yield back up to 3%.
Love it or hate it, the second biggest U.S. financial firm has been receiving plenty of unwanted media coverage.
You should own shares for the same reasons some investors have ponied up a $1 billion stake in this shareholder-friendly energy company.
Morgan Stanley visionary CEO James Gorman transformed this firm into a wealth management, financial services company offering investors an exciting return on their investment.